Search research articles
Contact Us
Filters
Showing results (31-40 of 41) with videos related to
Page
of 5
Sort By:
Molecular Endocrinology (Baltimore, Md.)
|
September 10, 1998
The DNA-binding and tau2 transactivation domains of the rat glucocorticoid receptor constitute a nuclear matrix-targeting signal
Y Tang, R H Getzenberg, B N Vietmeier, et al.
The Journal of Cell Biology
|
March 1, 1994
NIH3T3 cells expressing the deleted in colorectal cancer tumor suppressor gene product stimulate neurite outgrowth in rat PC12 pheochromocytoma cells
W E Pierceall, K R Cho, R H Getzenberg, et al.
Cancer Research
|
February 15, 1993
Nuclear matrix protein patterns in human benign prostatic hyperplasia and prostate cancer
A W Partin, R H Getzenberg, M J CarMichael, et al.
Cancer Research
|
April 1, 1996
Bladder cancer-associated nuclear matrix proteins
R H Getzenberg, B R Konety, T A Oeler, et al.
The Journal of Urology
|
August 23, 2000
Clinical usefulness of the novel marker BLCA-4 for the detection of bladder cancer
B R Konety, T S Nguyen, G Brenes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 29, 2000
Detection of bladder cancer using a novel nuclear matrix protein, BLCA-4
B R Konety, T S Nguyen, R Dhir, et al.
Urologic Oncology
|
May 10, 2001
Efficacy of a synthetic lytic peptide in the treatment of prostate cancer
J A. Arlotti, T S. Cimino, T -S. Nguyen, et al.
The Journal of Urology
|
March 21, 1998
Identification of nuclear matrix protein alterations associated with renal cell carcinoma
B R Konety, A K Nangia, T S Nguyen, et al.
The Prostate
|
July 3, 1998
Workgroup 3: transgenic and reconstitution models of prostate cancer
J E Green, N M Greenberg, C L Ashendel, et al.
Urology
|
January 14, 1998
Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system
R H Getzenberg, B W Light, P E Lapco, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 41) with videos related to
Sort By:
Page
of 5
Molecular Endocrinology (Baltimore, Md.)
|
September 10, 1998
The DNA-binding and tau2 transactivation domains of the rat glucocorticoid receptor constitute a nuclear matrix-targeting signal
Y Tang, R H Getzenberg, B N Vietmeier, et al.
The Journal of Cell Biology
|
March 1, 1994
NIH3T3 cells expressing the deleted in colorectal cancer tumor suppressor gene product stimulate neurite outgrowth in rat PC12 pheochromocytoma cells
W E Pierceall, K R Cho, R H Getzenberg, et al.
Cancer Research
|
February 15, 1993
Nuclear matrix protein patterns in human benign prostatic hyperplasia and prostate cancer
A W Partin, R H Getzenberg, M J CarMichael, et al.
Cancer Research
|
April 1, 1996
Bladder cancer-associated nuclear matrix proteins
R H Getzenberg, B R Konety, T A Oeler, et al.
The Journal of Urology
|
August 23, 2000
Clinical usefulness of the novel marker BLCA-4 for the detection of bladder cancer
B R Konety, T S Nguyen, G Brenes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 29, 2000
Detection of bladder cancer using a novel nuclear matrix protein, BLCA-4
B R Konety, T S Nguyen, R Dhir, et al.
Urologic Oncology
|
May 10, 2001
Efficacy of a synthetic lytic peptide in the treatment of prostate cancer
J A. Arlotti, T S. Cimino, T -S. Nguyen, et al.
The Journal of Urology
|
March 21, 1998
Identification of nuclear matrix protein alterations associated with renal cell carcinoma
B R Konety, A K Nangia, T S Nguyen, et al.
The Prostate
|
July 3, 1998
Workgroup 3: transgenic and reconstitution models of prostate cancer
J E Green, N M Greenberg, C L Ashendel, et al.
Urology
|
January 14, 1998
Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system
R H Getzenberg, B W Light, P E Lapco, et al.
Page
of 5